BofA Securities Downgrades Annexon Biosciences (ANNX) to Neutral; GA advantages 'need to be clarified'

May 26, 2023 6:04 AM EDT Send to a Friend
(Updated - May 26, 2023 8:51 AM EDT)

BofA Securities analyst Tazeen Ahmad downgraded Annexon Biosciences (NASDAQ: ANNX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login